These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10583616)

  • 1. The diagnostic role of the in vitro drug-induced interferon-gamma release test in Stevens-Johnson syndrome.
    Halevy S; Cohen AD; Livni E
    Int J Dermatol; 1999 Nov; 38(11):835-40. PubMed ID: 10583616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro test to confirm diagnosis of allopurinol-induced severe cutaneous adverse reactions.
    Klaewsongkram J; Thantiworasit P; Suthumchai N; Rerknimitr P; Sukasem C; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C
    Br J Dermatol; 2016 Nov; 175(5):994-1002. PubMed ID: 27106261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.
    Syu FK; Pan HY; Chuang PC; Huang YS; Cheng CY; Cheng FJ
    J Dermatol; 2018 Sep; 45(9):1080-1087. PubMed ID: 29963717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased in vitro release of interferon-gamma from ampicillin-stimulated peripheral blood mononuclear cells in Stevens-Johnson syndrome.
    Yoshimura T; Hamaguchi E; Usami E; Nakashima K; Kawaguchi M; Suzuki N; Okamoto Y; Nakao T; Yamazaki F
    Biol Pharm Bull; 2004 Jun; 27(6):929-31. PubMed ID: 15187450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol-Induced Stevens-Johnson Syndrome.
    Gupta SS; Sabharwal N; Patti R; Kupfer Y
    Am J Med Sci; 2019 Apr; 357(4):348-351. PubMed ID: 30638600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Lee HY; Pang SM; Thamotharampillai T
    J Am Acad Dermatol; 2008 Aug; 59(2):352-3. PubMed ID: 18638633
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
    Yeo SI
    Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.
    Chung WH; Pan RY; Chu MT; Chin SW; Huang YL; Wang WC; Chang JY; Hung SI
    J Invest Dermatol; 2015 Sep; 135(9):2237-2248. PubMed ID: 25946710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.
    Lu N; Rai SK; Terkeltaub R; Kim SC; Menendez ME; Choi HK
    Semin Arthritis Rheum; 2016 Oct; 46(2):253-258. PubMed ID: 27217070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopurinol in dermatology.
    Tsai TF; Yeh TY
    Am J Clin Dermatol; 2010; 11(4):225-32. PubMed ID: 20509717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency.
    Jung JW; Song WJ; Kim YS; Joo KW; Lee KW; Kim SH; Park HW; Chang YS; Cho SH; Min KU; Kang HR
    Nephrol Dial Transplant; 2011 Nov; 26(11):3567-72. PubMed ID: 21393610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol pharmacogenetics: assessment of potential clinical usefulness.
    Zineh I; Mummaneni P; Lyndly J; Amur S; La Grenade LA; Chang SH; Rogers H; Pacanowski MA
    Pharmacogenomics; 2011 Dec; 12(12):1741-9. PubMed ID: 22118056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact lens management of a case of Stevens-Johnson syndrome: a case report.
    Fine P; Savrinski B; Millodot M
    Optometry; 2003 Oct; 74(10):659-64. PubMed ID: 14606579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol and piroxicam.
    Xiong H; Liu G; Xiao J; Han Y; Liu T; Wan J; Yang J; Ding J; Dong X
    Eur J Dermatol; 2020 Oct; 30(5):620-621. PubMed ID: 33185537
    [No Abstract]   [Full Text] [Related]  

  • 17. Human leukocyte antigen-B*58:01 allele in a familial case of Stevens-Johnson syndrome induced by allopurinol.
    Caldarola G; Sollena P; Peris K; De Simone C
    J Dermatol; 2015 Jul; 42(7):753-4. PubMed ID: 25899558
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.
    Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A
    Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?
    Dainichi T; Uchi H; Moroi Y; Furue M
    Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapidly Progressing Severe Cutaneous Adverse Reaction With Acute Kidney Injury After Drug Exposure: An Uncommon Presentation.
    Rodgers BK; Kumar AB
    Am J Ther; 2016; 23(3):e916-9. PubMed ID: 24832386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.